Page last updated: 2024-10-16

carbamates and Ambulation Disorders, Neurologic

carbamates has been researched along with Ambulation Disorders, Neurologic in 1 studies

Research Excerpts

ExcerptRelevanceReference
" The slopes of the exposure-response relationship for probability of dizziness and abnormal coordination were similar to that for efficacy, whereas the slopes for dysarthria, somnolence, tremor, and blurred vision were shallower, indicating that the probability of these events occurring was less affected than the probability of efficacy by increases in retigabine/ezogabine AUC0-τ."5.17Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures. ( Berry, NS; Crean, CS; Reeve, R; Tompson, DJ, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tompson, DJ1
Crean, CS1
Reeve, R1
Berry, NS1

Trials

1 trial available for carbamates and Ambulation Disorders, Neurologic

ArticleYear
Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
    Clinical therapeutics, 2013, Volume: 35, Issue:8

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamates; Disorders of Excessive Somnolence; Dizziness;

2013